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A - Mammogram, Craniocaudal view B - Mammogram, Madeiolateral view C - BSGI
76 year old woman with history of stage 2 cancer of the right breast 12 years ago treated with breast conservation therapy. new lesion 
right axillary tail. incisdental large lobular carcinoma of the left breast discovered on BSGI
MethodsIntroduction
Although mammography is the gold standard for screening for breast cancer, 10 
to 15% of lesions are missed, and this is higher with dense breasts. Alternative 
diagnostic modalities are being developed. One of these, breast specific gamma 
imaging (BSGI), which is not effected by dense tissue, utilizes the increased 
metabolic activity of tumors to localize and distinguish benign from malignant 
processes in the breast. The test can be used for screening and diagnostic 
purposes.
These preliminary findings indicate a high sensitivity and specificity for BSGI 
similar to what other investigators have found, with results comparable to MRI. 
BSGI is simpler, less expensive, without a claustrophobic setting or prone 
positioning and with no contraindications for any metal in patients. Results are 
available immediately with only one screen or film to interpret.
BSGI shows great promise in detecting breast cancer. These preliminary results 
have prompted a multi-institutional prospective study in the near future.
Conclusions
Indications for BSGI included patients with: 1) recently diagnosed breast cancer 
to look for multifocality and multicentricity. 2) BRCA mutations. 3) past history of 
breast cancer/recurrence, 3) multiple masses on mammography and/or 
ultrasound, 4) unexplained pain or palpable abnormalities, 5) extremely dense 
breasts, and 6) indeterminate calcifications.
Of the 421 women who underwent BSGI, 28 also had MRI.
Results were analyzed by BIRADS categories. Seven of 8 patients were classified 
as BIRADS 5 or 6 on BSGI also had a positive MRI. All 7 patients that had a 
positive BSGI and MRI had a positive biopsy for cancer. One patient negative on 
MRI was also negative on biopsy. This would indicate a sensitivity of 87.5% and a 
specificity of 87.5% for BIRADS 5 and 6 patients.
Six of 15 patients classified as BIRADS 4 on BSGI had concurrent MRI 
classification. Three of 5 patients with BIRADS 3 on MRI were thought to have 
fibroadenomas and 4 others were BIRADS 2 on MRI.
Results
Using review of radiographs and medical records, we reviewed our experience 
with BSGI from 5/01/06 to 5/01/07. Demographic information, indications for 
study and results of BSGI were collected along with available mammography, 
ultrasound and MRI examinations.
